• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

评估阿尔茨海默病和帕金森病的常见分子基础。

Evaluation of the Common Molecular Basis in Alzheimer's and Parkinson's Diseases.

机构信息

Department of Computer Science, Virginia Commonwealth University, Richmond, VA 23284, USA.

Institute of Biological Sciences, Federal University of Para, Belem-PA 66075-110, Brazil.

出版信息

Int J Mol Sci. 2019 Jul 30;20(15):3730. doi: 10.3390/ijms20153730.

DOI:10.3390/ijms20153730
PMID:31366155
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6695669/
Abstract

Alzheimer's disease (AD) and Parkinson's disease (PD) are the most common neurodegenerative disorders related to aging. Though several risk factors are shared between these two diseases, the exact relationship between them is still unknown. In this paper, we analyzed how these two diseases relate to each other from the genomic, epigenomic, and transcriptomic viewpoints. Using an extensive literature mining, we first accumulated the list of genes from major genome-wide association (GWAS) studies. Based on these GWAS studies, we observed that only one gene () was shared between AD and PD. A subsequent literature search identified a few other genes involved in these two diseases, among which SIRT1 seemed to be the most prominent one. While we listed all the miRNAs that have been previously reported for AD and PD separately, we found only 15 different miRNAs that were reported in both diseases. In order to get better insights, we predicted the gene co-expression network for both AD and PD using network analysis algorithms applied to two GEO datasets. The network analysis revealed six clusters of genes related to AD and four clusters of genes related to PD; however, there was very low functional similarity between these clusters, pointing to insignificant similarity between AD and PD even at the level of affected biological processes. Finally, we postulated the putative epigenetic regulator modules that are common to AD and PD.

摘要

阿尔茨海默病(AD)和帕金森病(PD)是与衰老相关的最常见的神经退行性疾病。尽管这两种疾病有几个共同的风险因素,但它们的确切关系仍不清楚。在本文中,我们从基因组、表观基因组和转录组的角度分析了这两种疾病之间的关系。通过广泛的文献挖掘,我们首先从主要全基因组关联(GWAS)研究中积累了基因列表。基于这些 GWAS 研究,我们观察到 AD 和 PD 之间只有一个基因()共享。随后的文献搜索确定了这两种疾病涉及的其他一些基因,其中 SIRT1 似乎最为突出。虽然我们分别列出了以前报道过的 AD 和 PD 的所有 miRNA,但我们只发现了在两种疾病中都有报道的 15 个不同的 miRNA。为了获得更好的见解,我们使用应用于两个 GEO 数据集的网络分析算法对 AD 和 PD 进行了基因共表达网络预测。网络分析揭示了与 AD 相关的六个基因簇和与 PD 相关的四个基因簇;然而,这些簇之间的功能相似性非常低,这表明 AD 和 PD 之间即使在受影响的生物过程水平上也没有显著的相似性。最后,我们假设了 AD 和 PD 共有的潜在表观遗传调节模块。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8a7b/6695669/362b5a88090b/ijms-20-03730-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8a7b/6695669/b5a385d16c4d/ijms-20-03730-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8a7b/6695669/a07f5d7c45dc/ijms-20-03730-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8a7b/6695669/07eb41987951/ijms-20-03730-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8a7b/6695669/b36d0e786ec1/ijms-20-03730-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8a7b/6695669/b084e855d2c4/ijms-20-03730-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8a7b/6695669/8d0c97ad8e8a/ijms-20-03730-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8a7b/6695669/362b5a88090b/ijms-20-03730-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8a7b/6695669/b5a385d16c4d/ijms-20-03730-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8a7b/6695669/a07f5d7c45dc/ijms-20-03730-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8a7b/6695669/07eb41987951/ijms-20-03730-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8a7b/6695669/b36d0e786ec1/ijms-20-03730-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8a7b/6695669/b084e855d2c4/ijms-20-03730-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8a7b/6695669/8d0c97ad8e8a/ijms-20-03730-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8a7b/6695669/362b5a88090b/ijms-20-03730-g007.jpg

相似文献

1
Evaluation of the Common Molecular Basis in Alzheimer's and Parkinson's Diseases.评估阿尔茨海默病和帕金森病的常见分子基础。
Int J Mol Sci. 2019 Jul 30;20(15):3730. doi: 10.3390/ijms20153730.
2
An integrated approach to unravel a putative crosstalk network in Alzheimer's disease and Parkinson's disease.一种综合方法来揭示阿尔茨海默病和帕金森病中假定的串扰网络。
Neuropeptides. 2020 Oct;83:102078. doi: 10.1016/j.npep.2020.102078. Epub 2020 Aug 12.
3
Identifying the Association Between Alzheimer's Disease and Parkinson's Disease Using Genome-Wide Association Studies and Protein-Protein Interaction Network.利用全基因组关联研究和蛋白质-蛋白质相互作用网络确定阿尔茨海默病与帕金森病之间的关联。
Mol Neurobiol. 2015 Dec;52(3):1629-1636. doi: 10.1007/s12035-014-8946-8. Epub 2014 Nov 5.
4
Preliminary study to identify CXCR4 inhibitors as potential therapeutic agents for Alzheimer's and Parkinson's diseases.作为潜在的治疗阿尔茨海默病和帕金森病的药物,对 CXCR4 抑制剂进行初步研究。
Integr Biol (Camb). 2023 Apr 11;15. doi: 10.1093/intbio/zyad012.
5
Pinpointing novel risk loci for Lewy body dementia and the shared genetic etiology with Alzheimer's disease and Parkinson's disease: a large-scale multi-trait association analysis.确定路易体痴呆的新风险基因座以及与阿尔茨海默病和帕金森病的共享遗传病因:一项大规模多特征关联分析。
BMC Med. 2022 Jun 22;20(1):214. doi: 10.1186/s12916-022-02404-2.
6
Pathway analysis of two amyotrophic lateral sclerosis GWAS highlights shared genetic signals with Alzheimer's disease and Parkinson's disease.两项肌萎缩侧索硬化症 GWAS 的通路分析突出了与阿尔茨海默病和帕金森病的共享遗传信号。
Mol Neurobiol. 2015 Feb;51(1):361-9. doi: 10.1007/s12035-014-8673-1. Epub 2014 Mar 20.
7
Genetic networks in Parkinson's and Alzheimer's disease.帕金森病和阿尔茨海默病中的遗传网络。
Aging (Albany NY). 2020 Mar 23;12(6):5221-5243. doi: 10.18632/aging.102943.
8
Revealing the Modular Similarities and Differences Among Alzheimer's Disease, Vascular Dementia, and Parkinson's Disease in Genomic Networks.揭示基因组网络中阿尔茨海默病、血管性痴呆和帕金森病的模块相似性和差异性。
Neuromolecular Med. 2022 Jun;24(2):125-138. doi: 10.1007/s12017-021-08670-2. Epub 2021 Jun 12.
9
Integrating single-nucleus sequence profiling to reveal the transcriptional dynamics of Alzheimer's disease, Parkinson's disease, and multiple sclerosis.整合单细胞序列分析揭示阿尔茨海默病、帕金森病和多发性硬化症的转录动态。
J Transl Med. 2023 Sep 21;21(1):649. doi: 10.1186/s12967-023-04516-6.
10
Genetic insights into immune mechanisms of Alzheimer's and Parkinson's disease.遗传对阿尔茨海默病和帕金森病免疫机制的深入了解。
Front Immunol. 2023 Jun 8;14:1168539. doi: 10.3389/fimmu.2023.1168539. eCollection 2023.

引用本文的文献

1
Nanomaterials that Aid in the Diagnosis and Treatment of Alzheimer's Disease, Resolving Blood-Brain Barrier Crossing Ability.有助于阿尔茨海默病诊断和治疗的纳米材料,解决血脑屏障穿透能力问题。
Adv Sci (Weinh). 2024 Oct;11(38):e2403473. doi: 10.1002/advs.202403473. Epub 2024 Aug 5.
2
KAT8 beyond Acetylation: A Survey of Its Epigenetic Regulation, Genetic Variability, and Implications for Human Health.KAT8 超越乙酰化:对其表观遗传调控、遗传变异性及其对人类健康影响的综述。
Genes (Basel). 2024 May 17;15(5):639. doi: 10.3390/genes15050639.
3
Diagnostic value of plasma SIRT1 levels and whole-brain gray matter volume in Parkinson's disease patients with cognitive impairment.

本文引用的文献

1
Mitochondria in Neuroprotection by Phytochemicals: Bioactive Polyphenols Modulate Mitochondrial Apoptosis System, Function and Structure.植物化学物质在神经保护中的作用:生物活性多酚调节线粒体凋亡系统、功能和结构。
Int J Mol Sci. 2019 May 17;20(10):2451. doi: 10.3390/ijms20102451.
2
Genetic meta-analysis of diagnosed Alzheimer's disease identifies new risk loci and implicates Aβ, tau, immunity and lipid processing.基于诊断的阿尔茨海默病的全基因组关联荟萃分析鉴定出新的风险位点,并提示 Aβ、tau、免疫和脂类代谢过程的作用。
Nat Genet. 2019 Mar;51(3):414-430. doi: 10.1038/s41588-019-0358-2. Epub 2019 Feb 28.
3
Systematic Review of miRNA as Biomarkers in Alzheimer's Disease.
血浆 SIRT1 水平和全脑灰质体积对帕金森病伴认知障碍患者的诊断价值。
Neurol Sci. 2024 Jan;45(1):47-54. doi: 10.1007/s10072-023-07071-6. Epub 2023 Sep 18.
4
New insights into Sirt1: potential therapeutic targets for the treatment of cerebral ischemic stroke.Sirt1的新见解:治疗脑缺血性中风的潜在治疗靶点
Front Cell Neurosci. 2023 Aug 9;17:1228761. doi: 10.3389/fncel.2023.1228761. eCollection 2023.
5
Non-coding RNAs in Alzheimer's disease: perspectives from omics studies.阿尔茨海默病中的非编码 RNA:组学研究的视角。
Hum Mol Genet. 2022 Oct 20;31(R1):R54-R61. doi: 10.1093/hmg/ddac202.
6
Editorial to the Special Issue "Lipidomics and Neurodegenerative Diseases".特刊编辑寄语:脂组学与神经退行性疾病
Int J Mol Sci. 2021 Jan 28;22(3):1270. doi: 10.3390/ijms22031270.
7
Environment and Gene Association With Obesity and Their Impact on Neurodegenerative and Neurodevelopmental Diseases.环境与基因与肥胖的关联及其对神经退行性疾病和神经发育疾病的影响。
Front Neurosci. 2020 Aug 28;14:863. doi: 10.3389/fnins.2020.00863. eCollection 2020.
8
NaSH increases SIRT1 activity and autophagy flux through sulfhydration to protect SH-SY5Y cells induced by MPP~.NaSH 通过巯基化增加 SIRT1 活性和自噬通量,以保护 MPP~诱导的 SH-SY5Y 细胞。
Cell Cycle. 2020 Sep;19(17):2216-2225. doi: 10.1080/15384101.2020.1804179. Epub 2020 Aug 13.
miRNA 在阿尔茨海默病中的生物标志物:系统综述
Mol Neurobiol. 2019 Sep;56(9):6156-6167. doi: 10.1007/s12035-019-1500-y. Epub 2019 Feb 8.
4
Genome-wide meta-analysis identifies new loci and functional pathways influencing Alzheimer's disease risk.全基因组荟萃分析确定了新的位点和功能途径,影响阿尔茨海默病的风险。
Nat Genet. 2019 Mar;51(3):404-413. doi: 10.1038/s41588-018-0311-9. Epub 2019 Jan 7.
5
miRWalk: An online resource for prediction of microRNA binding sites.miRWalk:一个用于预测 microRNA 结合位点的在线资源。
PLoS One. 2018 Oct 18;13(10):e0206239. doi: 10.1371/journal.pone.0206239. eCollection 2018.
6
TAM 2.0: tool for MicroRNA set analysis.TAM 2.0:MicroRNA 集分析工具。
Nucleic Acids Res. 2018 Jul 2;46(W1):W180-W185. doi: 10.1093/nar/gky509.
7
miRNA-based signatures in cerebrospinal fluid as potential diagnostic tools for early stage Parkinson's disease.脑脊液中基于微小RNA的特征作为早期帕金森病的潜在诊断工具
Oncotarget. 2018 Apr 3;9(25):17455-17465. doi: 10.18632/oncotarget.24736.
8
DIANA-TarBase v8: a decade-long collection of experimentally supported miRNA-gene interactions.DIANA-TarBase v8:一个长达十年的实验支持的 miRNA-基因相互作用集合。
Nucleic Acids Res. 2018 Jan 4;46(D1):D239-D245. doi: 10.1093/nar/gkx1141.
9
Hidden heterogeneity in Alzheimer's disease: Insights from genetic association studies and other analyses.阿尔茨海默病的潜在异质性:遗传关联研究及其他分析的启示。
Exp Gerontol. 2018 Jul 1;107:148-160. doi: 10.1016/j.exger.2017.10.020. Epub 2017 Oct 26.
10
A 9-microRNA Signature in Serum Serves as a Noninvasive Biomarker in Early Diagnosis of Alzheimer's Disease.血清中 9 种 microRNA 标志物作为阿尔茨海默病早期诊断的无创性生物标志物。
J Alzheimers Dis. 2017;60(4):1365-1377. doi: 10.3233/JAD-170343.